PT90806A - Processo para a preparacao de antibiotico bu-3420t antitumor, de composicoes farmaceuticas que o contem e metodo para inibir o desenvolvimento de tumores em mamiferos e para tratamento de animais com uma infeccao bacteriana ou fungica - Google Patents

Processo para a preparacao de antibiotico bu-3420t antitumor, de composicoes farmaceuticas que o contem e metodo para inibir o desenvolvimento de tumores em mamiferos e para tratamento de animais com uma infeccao bacteriana ou fungica

Info

Publication number
PT90806A
PT90806A PT90806A PT9080689A PT90806A PT 90806 A PT90806 A PT 90806A PT 90806 A PT90806 A PT 90806A PT 9080689 A PT9080689 A PT 9080689A PT 90806 A PT90806 A PT 90806A
Authority
PT
Portugal
Prior art keywords
fungic
antitumor
tumors
antibiotic
mammals
Prior art date
Application number
PT90806A
Other languages
English (en)
Other versions
PT90806B (pt
Inventor
Masataka Konishi
Toshikazu Oki
Hiroaki Ohkuma
Kiyoshi Matsumoto
Yutaka Hoshino
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PT90806A publication Critical patent/PT90806A/pt
Publication of PT90806B publication Critical patent/PT90806B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P15/00Preparation of compounds containing at least three condensed carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/29Micromonospora
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/867Micromonospora

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT90806A 1988-06-10 1989-06-09 Processo para a preparacao de antibiotico bu-3420t antitumor, de composicoes farmaceuticas que o contem e metodo para inibir o desenvolvimento de tumores em mamiferos e para tratamento de animais com uma infeccao bacteriana ou fungica PT90806B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/208,330 US4916065A (en) 1988-06-10 1988-06-10 BU-3420T Antitumor antibiotic

Publications (2)

Publication Number Publication Date
PT90806A true PT90806A (pt) 1989-12-29
PT90806B PT90806B (pt) 1994-10-31

Family

ID=22774189

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90806A PT90806B (pt) 1988-06-10 1989-06-09 Processo para a preparacao de antibiotico bu-3420t antitumor, de composicoes farmaceuticas que o contem e metodo para inibir o desenvolvimento de tumores em mamiferos e para tratamento de animais com uma infeccao bacteriana ou fungica

Country Status (15)

Country Link
US (1) US4916065A (pt)
EP (1) EP0350623A3 (pt)
JP (1) JPH02117676A (pt)
KR (1) KR910005631B1 (pt)
AU (1) AU633826B2 (pt)
DK (1) DK283489A (pt)
FI (1) FI892788A (pt)
HU (3) HU202591B (pt)
IL (1) IL90548A (pt)
MY (1) MY104032A (pt)
NO (1) NO892328L (pt)
NZ (1) NZ229460A (pt)
PT (1) PT90806B (pt)
YU (1) YU46768B (pt)
ZA (1) ZA894393B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT94638A (pt) * 1989-07-10 1991-03-20 Bristol Myers Squibb Co Processo para a preparacao do antibiotico bu-3889v com actividade antiviral e de composicoes farmaceuticas que o contem
US5098708A (en) * 1990-06-14 1992-03-24 Bristol-Myers Squibb Company Antiviral antibiotic BU-3889V
US5116845A (en) * 1990-05-04 1992-05-26 Bristol-Myers Company BU-3420T antitumor antibiotic
US5066585A (en) * 1990-07-09 1991-11-19 Board Of Trustees Operating Michigan State University Method of inhibiting fungus using novel antifungal compounds
IE66159B1 (en) * 1990-08-01 1995-12-13 Scripps Research Inst Dynemicin analogs: synthesis methods of preparation and use
WO1992002522A1 (en) * 1990-08-01 1992-02-20 Scripps Clinic And Research Foundation Dynemicin analogs: syntheses, methods of preparation and use
US5162330A (en) * 1990-11-05 1992-11-10 Bristol-Myers Squibb Co. Dynemicin c antibiotic, its triacetyl derivative and pharmaceutical composition containing same
WO1996003124A1 (en) * 1994-07-27 1996-02-08 California Institute Of Technology Dynemicin analogs
EP1470241A2 (en) * 2002-01-24 2004-10-27 Ecopia Biosciences Inc. Method, system and knowledge repository for identifying a secondary metabolite from a microorganism

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
US4675187A (en) * 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
US4594248A (en) * 1985-03-15 1986-06-10 Warner-Lambert Company CL-1577-B4 compound, its production and use
IL79519A0 (en) * 1985-08-27 1986-10-31 Bristol Myers Co Bbm-1675c and d antitumor antibiotics

Also Published As

Publication number Publication date
HU901778D0 (en) 1990-06-28
YU46768B (sh) 1994-05-10
AU633826B2 (en) 1993-02-11
AU3633889A (en) 1989-12-21
HU202591B (en) 1991-03-28
JPH02117676A (ja) 1990-05-02
NO892328D0 (no) 1989-06-07
KR900000482A (ko) 1990-01-30
IL90548A0 (en) 1990-01-18
KR910005631B1 (ko) 1991-08-01
NZ229460A (en) 1992-02-25
DK283489A (da) 1989-12-11
HU205932B (en) 1992-07-28
DK283489D0 (da) 1989-06-09
FI892788A0 (fi) 1989-06-07
ZA894393B (en) 1990-09-26
EP0350623A2 (en) 1990-01-17
NO892328L (no) 1989-12-11
YU118589A (en) 1991-04-30
IL90548A (en) 1994-01-25
EP0350623A3 (en) 1991-07-03
PT90806B (pt) 1994-10-31
FI892788A (fi) 1989-12-11
MY104032A (en) 1993-10-30
HUT57774A (en) 1991-12-30
US4916065A (en) 1990-04-10
HUT52163A (en) 1990-06-28

Similar Documents

Publication Publication Date Title
BR9507502A (pt) Formulação de tablete processo de tratamento de infecções bacteriais em seres humanos ou em animais processo para preparação de uma formulação de tablete uso de uma formulação de tablete e processo de tratamento de uma infeção bacterial em um paciente humano
BR9500659A (pt) Composto composição farmacêutica e método de tratamento ou prevenção de uma condição causada por uma injeção bacteriana
BR8803442A (pt) Polissacarideo,processo para a preparacao de polissacarideos,medicamento para uso humano ou animal e aditivo alimentar
BR9602856A (pt) Composição de polissacarídeo enxertado método para o tratamento de artrite em mamíferos e para a preparação de polissacarídeo enxertado com antioxidante
BR9510423A (pt) Formulação lipossomal multilamelar de baixa rigidez processo de tratamento ou de profilaxia de uma infecção bacteriana em um animal e de uma variante mucoìde da mesma, uso da formulação lipossomal antibacteriana
NO873753D0 (no) Periodisk biologisk luftbehandlingsprosess og system for denne.
EP0447523A4 (en) Compositions and methods for treating or preventing infections in canine and feline animals
PT90592A (pt) Processo para a preparacao do antibiotico galidermina e de composicoes farmaceuticas e cosmeticas que o contem
BR9706341A (pt) Processo para pbtenção de rações e ingredientes para nutrição animal resistentes à contaminações bacterianas
PT90806A (pt) Processo para a preparacao de antibiotico bu-3420t antitumor, de composicoes farmaceuticas que o contem e metodo para inibir o desenvolvimento de tumores em mamiferos e para tratamento de animais com uma infeccao bacteriana ou fungica
AU587065B2 (en) Composition and method for treating animals
EP0315539A3 (fr) Esters aromatiques polycycliques d'antibiotiques macrolidiques et lincosamidiques, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
BR9708864A (pt) Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero
DE69306768D1 (de) Medizinischer oder veterinaerer injektionsapparat
BR9303818A (pt) Composiçoes nutritivas ou medicamentosas para administraçao aos ruminantes e processo de preparaçao das mesmas
BR9504119A (pt) Composto composiçao farmacêutica métodos para tratar uma infecçao bacteriana e uma infecçao micoplásmica
IL90187A0 (en) Method for treating an auto-immune disease using succinyl-acetone and pharmaceutical compositions containing the same
EG18213A (en) Pharmaceutical formulation for the treatment of bacterial infections
GB2255718B (en) Pharmaceutical composition for treating bacterial and / or viral infection
PT85625A (pt) Dispositivo para abertura de galerias com proteccao da lamina e processo para abertura e/ou o acabamento de galerias ou semelhantes
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
FI916116A0 (fi) Menetelmä siipikarjan Campylobakteeri-infektioiden ennaltaehkäisemiseen käyttökelpoisen bakteerivalmisteen valmistamiseksi
DE68902792D1 (de) Mittel zur kosmetischen oder pharmazeutischen verwendung.
GR3003852T3 (pt)

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940420

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19951031